286 related articles for article (PubMed ID: 33557763)
1. Circulating level of microRNA-142-5p is a potential biomarker for predicting in-stent restenosis: a case-control study.
Pan CH; Chien SC; Chen CJ; Shih CM; Hsieh MH; Huang CY; Bi WF; Chan CS; Kao YT; Hsiao CY; Chiang SJ; Chiang KH; Huang JH; Liu YR; Luo JD; Huang HY; Wu CH
BMC Cardiovasc Disord; 2021 Feb; 21(1):77. PubMed ID: 33557763
[TBL] [Abstract][Full Text] [Related]
2. Differentially expressed miR-152, a potential biomarker for in-stent restenosis (ISR) in peripheral blood mononuclear cells (PBMCs) of coronary artery disease (CAD) patients.
Maheronnaghsh M; Niktab I; Enayati S; Amoli MM; Hosseini SK; Tavakkoly-Bazzaz J
Nutr Metab Cardiovasc Dis; 2021 Apr; 31(4):1137-1147. PubMed ID: 33712363
[TBL] [Abstract][Full Text] [Related]
3. Potential of circulating pro-angiogenic microRNA expressions as biomarkers for rapid angiographic stenotic progression and restenosis risks in coronary artery disease patients underwent percutaneous coronary intervention.
Dai R; Liu Y; Zhou Y; Xiong X; Zhou W; Li W; Zhou W; Chen M
J Clin Lab Anal; 2020 Jan; 34(1):e23013. PubMed ID: 31495986
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Value of Circulating microRNAs for In-Stent Restenosis in Patients with Lower Extremity Arterial Occlusive Disease.
Yuan L; Dong J; Zhu G; Bao J; Lu Q; Zhou J; Jing Z
Sci Rep; 2019 Feb; 9(1):1402. PubMed ID: 30718561
[TBL] [Abstract][Full Text] [Related]
5. Association of high level of hs-CRP with in-stent restenosis: A case-control study.
Baktashian M; Saffar Soflaei S; Kosari N; Salehi M; Khosravi A; Ahmadinejad M; Moohebati M; Ebrahimi M; Rahmani F; Khameneh-Bagheri R; Ahmadi M; Sadabadi F; Tayefi M; Bazhdanzadeh S; Ferns GA; Hashemi SM; Pasdar A; Ghayour-Mobarhan M
Cardiovasc Revasc Med; 2019 Jul; 20(7):583-587. PubMed ID: 30232022
[TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs as potential noninvasive biomarkers for in-stent restenosis.
He M; Gong Y; Shi J; Pan Z; Zou H; Sun D; Tu X; Tan X; Li J; Li W; Liu B; Xue J; Sheng L; Xiu C; Yang N; Xue H; Ding X; Yu C; Li Y
PLoS One; 2014; 9(11):e112043. PubMed ID: 25427155
[TBL] [Abstract][Full Text] [Related]
7. Coronary CT angiography-derived quantitative markers for predicting in-stent restenosis.
Tesche C; De Cecco CN; Vliegenthart R; Duguay TM; Stubenrauch AC; Rosenberg RD; Varga-Szemes A; Bayer RR; Yang J; Ebersberger U; Baquet M; Jochheim D; Hoffmann E; Steinberg DH; Chiaramida SA; Schoepf UJ
J Cardiovasc Comput Tomogr; 2016; 10(5):377-83. PubMed ID: 27431607
[TBL] [Abstract][Full Text] [Related]
8. Role of red blood cell distribution in predicting drug-eluting stent restenosis in patients with stable angina pectoris after coronary stenting.
Zhao K; Li YJ; Gao S
Coron Artery Dis; 2015 May; 26(3):220-4. PubMed ID: 25647458
[TBL] [Abstract][Full Text] [Related]
9. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
[TBL] [Abstract][Full Text] [Related]
10. Circulating miRNA-23b and miRNA-143 Are Potential Biomarkers for In-Stent Restenosis.
Saavedra N; Rojas G; Herrera J; Rebolledo C; Ruedlinger J; Bustos L; Bobadilla B; Pérez L; Saavedra K; Zambrano T; Lanas F; Salazar LA
Biomed Res Int; 2020; 2020():2509039. PubMed ID: 33015157
[TBL] [Abstract][Full Text] [Related]
11. Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study.
Qin Z; Zhou K; Li YP; Wang JL; Cheng WJ; Hu CP; Shi C; He H; Zhou YJ
Cardiovasc Diabetol; 2019 Jan; 18(1):11. PubMed ID: 30691501
[TBL] [Abstract][Full Text] [Related]
12. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNA-21 as Stable Blood-Based Markers for Patients With ISR After PCI.
Zhang X; Xiao XP; Ren XA; Xue W
Heart Surg Forum; 2020 Oct; 23(6):E756-E762. PubMed ID: 33234202
[TBL] [Abstract][Full Text] [Related]
14. Circulating miR-22-5p and miR-122-5p are promising novel biomarkers for diagnosis of acute myocardial infarction.
Wang Y; Chang W; Zhang Y; Zhang L; Ding H; Qi H; Xue S; Yu H; Hu L; Liu D; Zhu W; Wang Y; Li P
J Cell Physiol; 2019 Apr; 234(4):4778-4786. PubMed ID: 30256407
[TBL] [Abstract][Full Text] [Related]
15. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
16. The characteristics and risk factors of in-stent restenosis in patients with percutaneous coronary intervention: what can we do.
Wang P; Qiao H; Wang R; Hou R; Guo J
BMC Cardiovasc Disord; 2020 Dec; 20(1):510. PubMed ID: 33276720
[TBL] [Abstract][Full Text] [Related]
17. Association of Serum HMGB2 Levels With In-Stent Restenosis: HMGB2 Promotes Neointimal Hyperplasia in Mice With Femoral Artery Injury and Proliferation and Migration of VSMCs.
He YH; Wang XQ; Zhang J; Liu ZH; Pan WQ; Shen Y; Zhu ZB; Wang LJ; Yan XX; Yang K; Zhang RY; Shen WF; Ding FH; Lu L
Arterioscler Thromb Vasc Biol; 2017 Apr; 37(4):717-729. PubMed ID: 28183701
[TBL] [Abstract][Full Text] [Related]
18. Visit-to-visit HbA
Yang CD; Shen Y; Lu L; Yang ZK; Hu J; Zhang RY; Shen WF; Ding FH; Wang XQ
Cardiovasc Diabetol; 2020 Sep; 19(1):133. PubMed ID: 32887588
[TBL] [Abstract][Full Text] [Related]
19. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
[TBL] [Abstract][Full Text] [Related]
20. [Effects of miRNA-1,miRNA-21 in plasma on in-stent restenosis in patients with coronary heart disease and diabetes mellitus after percutaneous coronary intervention].
Guan JJ; Zhang Y; Liu YJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2018 Apr; 34(4):304-308 384. PubMed ID: 30788936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
